Compositions and methods for treating multiple sclerosis
US11998547B2 · kind B2 · utility
1Cited by
13References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2021 |
| Grant date | Jun 4, 2024 |
| Priority date | — |
| Expiry date | Aug 4, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compounds and compositions that inhibit the NLRP3 inflammasome, for example, a compound according to formula I Also disclosed are methods for treating multiple sclerosis using the compounds and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.